BJH - volume 3, issue 3, september 2012
J-F. Baurain MD, PhD, W. Lybaert MD
It has become a tradition to hold the biennial International Conference on Thrombosis and Haemostasis Issues in Cancer (ICTHIC) in Bergamo. Bergamo is a quiet town in Northern Italy located on a hilltop beyond the Alps. Over 700 physicians with different backgrounds but the same interest attended the meeting this year from April 20th to April 22nd. The meeting provides a unique opportunity for reviewing the different molecular and clinical findings on thrombosis and hemostasis issues in cancer and for updating the guidelines on prophylaxis and treatment of Venous Thrombo-Embolic Events (VTE) in cancer patients. This congress report covers several key topics: duration of prophylaxis in cancer patients undergoing surgery, prevention in medical cancer patients, type and duration of VTE treatment in cancer patients, place of the newer anti-thrombotic agents in cancer patients and survival advantage of Low-Weight Molecular Heparins (LWMH).
(BELG J MED ONCOL 2012;6:114–117)
Read moreBJH - volume 3, issue 1, march 2012
A. Bosly MD, PhD
In the plenary session of the 53rd Annual Meeting of the American Society of Hematology (ASH) December 10–13, 2011, San Diego, USA, six oral presentations were selected as the most important contributions to progress in haematology in 2011.
(BELG J HEMATOL 2012;3:27–8)
Read more
Top
